West African Network for TB, AIDS and Malaria (WANETAM III)

WANETAM is a network of institutions in West Africa and Europe focused on building sustainable expertise for conducting clinical trials and research on poverty-related diseases. The third phase of the project will include training, resource development, and surveillance activities to strengthen capacity and collaboration.WANETAM-3 will build on the activities of the disease-defined work packages (WPs): TB, Malaria, HIV, Neglected Tropical Diseases, Emerging Infections response and preparedness and the inclusion of the cross-cutting trainings that strengthens capacity of individuals in specialised skills needed in clinical research and the capacity of supporting infrastructure. The WPs will consolidate the mission to achieve sustainable capacity and multi-institutional collaboration in clinical research through activities. Researcher leadership trainings are also proposed through grant writing and mentorship masterclass training workshops, pilot studies and work-visits. Scientists will be supported for grant applications to achieve sustainability. The generation of data will increase during WANETAM-3 from the TB multi-drug resistance surveillance and diagnostic work, the Malaria elimination cluster-randomised studies and HIV drug-resistance cohorts and therefore, calls for the establishment of WANETAM database management and sharing platform. This project will also strengthen ethics capacity. The network will respond to the need to strengthen research in COVID-19; work will be done on the impact of covid-19 on the disease entities and support the partner laboratories in diagnosis and sequencing of Covid-19 strains.

Project detailsEDCTP Grants

Capacity Building
Diagnostics
Drug-based Strategies
Health Systems & Op. Research
Leadership & Governance
Surveillance

Aug 2021 — May 2025

$4.88M

Benin
Burkina Faso
France
Germany
Ghana
Mali
Nigeria
Portugal
Senegal
The Gambia
Togo

West African Network for TB, AIDS and Malaria (WANETAM I)